VREXVREXHealthcare · Medical Devices

VREX Stock Forecast: Varex Imaging Corp. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$18
−0.22% on the day

The median 12-month analyst price target for Varex Imaging Corp. is $19. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 81 of 100 as at 21 Nov 2026 — inside the top quartile.

Market cap
$770.7M
Ticker Nerd rank
81/ 100
Median analyst target
$19
Analysts covering
3
Revenue$210.5M+3.7% y/y
Operating income$22.8M
Net income$15.9M
Free cash flow$12.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
0.0%
1M
−1.6%
YTD
+55.4%
1Y
+75.9%
From 52W high
−2.6%
From 52W low
+94.2%
$9
$19
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Varex Imaging Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
81/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
99
Growth
92
Value
80
Issuance
71
Quality
68
Revisions
50
Volatility
33
Accruals
25

Momentum (99): The shares have been drifting up relative to others.

Accruals (25): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

VREX stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on VREX, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$12$14$16$18$20Jan 26Apr 26Jul 26Oct 26VREXHigh $19Median $19Low $19

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says3 analysts
0
Buy
3
Hold
0
Sell
$19
Low
$19
Median
$19
High
Recent analyst actionsNewest first
DateFirmActionRatingTarget
17 Aug 2026CJS SecuritiesDowngradeMarket Perform—
11 Aug 2026OppenheimerDowngradePerform—
10 Aug 2026Sidoti & Co.DowngradeNeutral$19
19 Nov 2025B. Riley SecuritiesReiteratesBuy$16
19 Nov 2025OppenheimerMaintainsOutperform$23 → $18
8 Aug 2025B. Riley SecuritiesMaintainsBuy—
7 Feb 2025B. Riley SecuritiesReiteratesBuy—
7 Feb 2025OppenheimerMaintainsOutperform—
23 Aug 2024B. Riley SecuritiesInitiatesBuy—
15 Nov 2023OppenheimerMaintainsOutperform—
2 Aug 2023OppenheimerReiteratesOutperform—
24 May 2023JefferiesMaintainsHold—
12 Oct 2022JefferiesInitiatesHold—
5 Feb 2021OppenheimerUpgradeOutperform—
13 Aug 2020OppenheimerDowngradePerform—
13 May 2020JefferiesMaintainsHold—
13 May 2020JP MorganDowngradeNeutral—
13 May 2020Sidoti & Co.MaintainsBuy—
25 Mar 2020JP MorganUpgradeOverweight—
12 Feb 2020JefferiesDowngradeHold—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for VREX.

Market Radar

This page is one stock. Monday covers all of them.

VREX appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

VREX vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Varex Imaging Corp. returned +75.9% against +6.9% for the S&P 500, dividends included.

VREX vs S&P 500, last 12 monthsTotal return, rebased to 100
80100120140160180Jan 26Apr 26Jul 26Oct 26VREXS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

VREX analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
+8.0%
Analysts raising
4
Analysts cutting
0
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
34.3×

Cheaper than 25% of US stocks

Price / sales
0.9×

Cheaper than 68% of US stocks

Price / book
1.5×

Cheaper than 53% of US stocks

EV / EBITDA
10.6×

Cheaper than 53% of US stocks

Growth & margins
Revenue growth (YoY)
3.7%

Higher than 37% of US stocks

Earnings growth (YoY)
—
Gross margin
36.4%

Higher than 44% of US stocks

Operating margin
8.3%

Higher than 60% of US stocks

Net margin
2.6%

Higher than 50% of US stocks

Returns & dividend
Return on equity
4.6%

Higher than 51% of US stocks

Return on assets
4.2%

Higher than 71% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Varex Imaging Corp. has a market value of $770.7M and an enterprise value of $1.1B.

  • Revenue in the twelve months to 30 June 2026: $865.0M. The latest quarter grew 3.7% year on year.

  • Net income over the same four quarters: $22.5M, a 2.6% net margin.

  • Diluted earnings per share, trailing twelve months: $0.52.

  • Free cash flow in the twelve months to 30 June 2026: −$20.2M.

  • Shares outstanding: 42.1M.

  • Trailing P/E: 34.3×; forward P/E: 17.0× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Varex Imaging Corp. employs 2,500 people — $346K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 21 Nov 2026

Data provided by Twelve Data

Peers

VREX and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
VREXVarex Imaging Corp.$770.7M81
CTKBCytek Biosciences, Inc.$790.4M95
INMDInMode Ltd.$713.9M85
BBNXBeta Bionics, Inc.$703.3M29
KIDSOrthoPediatrics Corp.$828.7M84
BVSBioventus, Inc.$832.5M93
AORTArtivion, Inc.$885.4M31

Take a look at VREX’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Varex Imaging Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about VREX

What is the VREX stock price forecast for 2026-2027?

The median 12-month analyst price target for Varex Imaging Corp. is $19. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is VREX stock a buy right now?

Of the 3 analysts covering Varex Imaging Corp., 0 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Varex Imaging Corp. 81 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank VREX?

As at 21 Nov 2026, Varex Imaging Corp. ranks 81 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Momentum (99 of 100).

Will VREX stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts is $19, and Ticker Nerd's factor model ranks Varex Imaging Corp. 81 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the VREX stock forecast for 2030?

No analyst covering Varex Imaging Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for VREX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $19 to $19 over the next 12 months.

How has VREX stock performed over the past year?

Varex Imaging Corp. returned +75.9% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Varex Imaging Corp. do?

Varex Imaging Corp. is a medical technology company that designs, manufactures, sells, and services X-ray imaging components and related systems. Varex Imaging Corp. serves two main business segments: Medical and Industrial.

Company

About Varex Imaging Corp.

Varex Imaging Corp. is a medical technology company that designs, manufactures, sells, and services X-ray imaging components and related systems. Varex Imaging Corp. serves two main business segments: Medical and Industrial. Its Medical segment supplies X-ray tubes, digital detectors, high-voltage connectors, image-processing software, workstations, and other components used in applications such as computed tomography, mammography, oncology, and general diagnostic imaging. Its Industrial segment provides X-ray accelerators, detectors, and inspection solutions for security screening, cargo inspection, and non-destructive testing. The company works primarily with original equipment manufacturers, independent service providers, distributors, and end users that integrate its products into imaging platforms. Headquartered in Salt Lake City, Utah, Varex Imaging Corp. plays a specialized role in the global imaging supply chain by providing critical technologies used to detect, diagnose, protect, and inspect across medical, industrial, and security markets.

CEO Mr. Sunny S. Sanyal · 2,500 employees · United States · https://www.vareximaging.com